Literature DB >> 24010719

Blau syndrome-associated uveitis and the NOD2 gene.

Parvathy Pillai1, Lucia Sobrin.   

Abstract

Blau syndrome (BS), a rare autosomal dominant autoinflammatory syndrome, is an example of a monogenic disease. It was first described as a classic triad of uveitis, arthritis, and exanthema, typically seen in patients less than four years of age. Since that time, the phenotype has been expanded to include fever, cranial neuropathies, cardiovascular abnormalities, and granulomas of the liver and kidney. The ocular inflammation is often a panuveitis that occurs later in the disease course and typically carries the greatest morbidity in BS. BS has been mapped to the chromosomal region 16q12-21, also known as the NOD2 gene (formerly CARD15/NOD2). The disease is secondary to a single amino acid mutation NOD2 that leads to peptidoglycan-independent activity of nuclear factor (NF)-κB. Clinical and genetic aspects of BS will be discussed, as well as recent advances in treatment protocols.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24010719     DOI: 10.3109/08820538.2013.825285

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  13 in total

Review 1.  Early-onset sarcoidosis caused by a rare CARD15/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature.

Authors:  Francesco La Torre; Giovanni Lapadula; Luca Cantarini; Orso Maria Lucherini; Florenzo Iannone
Journal:  Clin Rheumatol       Date:  2014-01-21       Impact factor: 2.980

Review 2.  Potential Benefits of TNF Targeting Therapy in Blau Syndrome, a NOD2-Associated Systemic Autoinflammatory Granulomatosis.

Authors:  Tomoko Matsuda; Naotomo Kambe; Riko Takimoto-Ito; Yoko Ueki; Satoshi Nakamizo; Megumu K Saito; Syuji Takei; Nobuo Kanazawa
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

Review 3.  NOD1 and NOD2 in inflammatory and infectious diseases.

Authors:  Bruno C Trindade; Grace Y Chen
Journal:  Immunol Rev       Date:  2020-07-17       Impact factor: 12.988

4.  A new mutation in blau syndrome.

Authors:  Cengiz Zeybek; Gokalp Basbozkurt; Davut Gul; Erkan Demirkaya; Faysal Gok
Journal:  Case Rep Rheumatol       Date:  2015-01-27

5.  NOD2 genetic variants and sarcoidosis-associated uveitis.

Authors:  Samaneh Davoudi; Daniel Navarro-Gomez; Lishuang Shen; Cindy Ung; Aiai Ren; Lynn Sullivan; Mindy Kwong; Maria Janessian; Jason Comander; Xiaowu Gai; Ann-Marie Lobo; George N Papaliodis; Lucia Sobrin
Journal:  Am J Ophthalmol Case Rep       Date:  2016-06-01

6.  Bilateral congenital macular coloboma and cataract: A case report.

Authors:  Canwei Zhang; Peng Wu; Luping Wang; Jing Gao; Xudong Huang; Yaqin Jiang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

7.  Blue Light Induces Impaired Autophagy through Nucleotide-Binding Oligomerization Domain 2 Activation on the Mouse Ocular Surface.

Authors:  Ying Li; Rujun Jin; Lan Li; Ji Suk Choi; Jonghwa Kim; Hyeon Jeong Yoon; Jong Hwan Park; Kyung Chul Yoon
Journal:  Int J Mol Sci       Date:  2021-02-18       Impact factor: 5.923

Review 8.  Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease.

Authors:  Francesco Caso; Paola Galozzi; Luisa Costa; Paolo Sfriso; Luca Cantarini; Leonardo Punzi
Journal:  RMD Open       Date:  2015-07-20

9.  Blau syndrome polymorphisms in NOD2 identify nucleotide hydrolysis and helical domain 1 as signalling regulators.

Authors:  Rhiannon Parkhouse; Joseph P Boyle; Tom P Monie
Journal:  FEBS Lett       Date:  2014-08-02       Impact factor: 4.124

Review 10.  Monogenic autoinflammatory diseases in children: single center experience with clinical, genetic, and imaging review.

Authors:  Alaa N Alsharief; Ronald M Laxer; Qiuyan Wang; Jennifer Stimec; Carina Man; Paul Babyn; Andrea S Doria
Journal:  Insights Imaging       Date:  2020-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.